Related Experiment Video
Updated: May 31, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
[Specificities of diabetes in acute coronary syndromes]
S Carballo1, D Carballo, P F Keller
1Service de médecine interne générale, Département des specialités de médecine, HUG, 1211 Genève 14. Sebastian.Carballo@hcuge.ch
Insights
Diabetes is a growing health issue, increasing risks for acute coronary syndromes (ACS). Diabetic patients with ACS benefit more from aggressive treatments but receive them less often than non-diabetic patients.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Diabetes mellitus is a significant and expanding global health concern.
- Diabetic patients with acute coronary syndromes (ACS) face elevated risks for subsequent cardiovascular events due to proatherosclerotic, proinflammatory, and prothrombotic states.
- Despite established benefits, evidence-based treatments for ACS are underutilized in diabetic populations.
Purpose of the Study:
- To highlight the increased cardiovascular risk in diabetic patients with ACS.
- To emphasize the superior benefit of aggressive platelet inhibition and early invasive strategies in diabetic ACS patients.
- To address the disparity in evidence-based treatment delivery between diabetic and non-diabetic ACS patients.
Main Methods:
- This study is a review of current literature on diabetes, ACS, and treatment outcomes.
- Comparative analysis of treatment efficacy and adherence in diabetic versus non-diabetic ACS patients.
- Examination of risk factors and their impact on cardiovascular event recurrence.
Main Results:
- Diabetic patients with ACS exhibit a higher risk of recurrent cardiovascular events compared to non-diabetic individuals.
- Diabetic patients demonstrate a greater positive response to aggressive platelet inhibition and early invasive management.
- There is a documented underuse of recommended evidence-based treatments in diabetic patients experiencing ACS.
Conclusions:
- Diabetic patients with ACS represent a high-risk group requiring optimized cardiovascular care.
- Aggressive antithrombotic therapy and early revascularization strategies are particularly beneficial for diabetic ACS patients.
- Improving the implementation of evidence-based guidelines in diabetic ACS patients is crucial to reduce cardiovascular morbidity and mortality.
Abstract:
Contrary to the decline in the prevalence of several risk factors such as hypertension, hypercholesterolemia and smoking, diabetes is an expanding health burden in the western world. Because of the proatherosclerotic, proinflammatory, and prothrombotic states associated with diabetes, diabetic patients with acute coronary syndromes (ACS) are at high risk of subsequent cardiovascular events. However, they derive greater benefit from aggressive platelet inhibition and an early invasive strategy than non-diabetic individuals. Despite the documented efficacy, diabetic patients with ACS receive evidence-based treatments less frequently than non-diabetic individuals.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Complications of Diabetes Mellitus
Acute Coronary Syndrome V: Nursing Management
Coronary Artery Disease III: Clinical Manifestations
